Verrica Pharma: CMO Departs, New Directors Elected
Ticker: VRCA · Form: 8-K · Filed: Aug 27, 2024 · CIK: 1660334
| Field | Detail |
|---|---|
| Company | Verrica Pharmaceuticals Inc. (VRCA) |
| Form Type | 8-K |
| Filed Date | Aug 27, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-election, executive-departure
TL;DR
Verrica Pharma's CMO is out, two new directors are in. Board shakeup.
AI Summary
Verrica Pharmaceuticals Inc. announced on August 21, 2024, the departure of its Chief Medical Officer, Dr. Robert L. Armstrong. The company also reported the election of two new directors, Dr. Paul L. Berns and Mr. David M. S. Johnson, to its Board of Directors, effective August 21, 2024. Additionally, the company disclosed compensatory arrangements for certain officers.
Why It Matters
The departure of a Chief Medical Officer and the addition of new directors can signal strategic shifts or changes in leadership focus for the company.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can indicate internal restructuring or strategic realignments that may impact future performance.
Key Players & Entities
- Verrica Pharmaceuticals Inc. (company) — Registrant
- Dr. Robert L. Armstrong (person) — Chief Medical Officer who departed
- Dr. Paul L. Berns (person) — Newly elected director
- Mr. David M. S. Johnson (person) — Newly elected director
- August 21, 2024 (date) — Date of earliest event reported and director elections
FAQ
Who has departed from Verrica Pharmaceuticals Inc.?
Dr. Robert L. Armstrong, the Chief Medical Officer, has departed from Verrica Pharmaceuticals Inc.
When was the departure of Dr. Robert L. Armstrong reported?
The departure was reported as of August 21, 2024.
Who were elected as new directors to Verrica Pharmaceuticals Inc.'s Board?
Dr. Paul L. Berns and Mr. David M. S. Johnson were elected as new directors.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is August 21, 2024.
What is Verrica Pharmaceuticals Inc.'s principal executive office address?
Verrica Pharmaceuticals Inc.'s principal executive office is located at 44 W. Gay St., Suite 400, West Chester, PA 19380.
Filing Stats: 556 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-08-27 16:50:01
Filing Documents
- d890208d8k.htm (8-K) — 23KB
- 0001193125-24-207814.txt ( ) — 142KB
- vrca-20240821.xsd (EX-101.SCH) — 3KB
- vrca-20240821_lab.xml (EX-101.LAB) — 18KB
- vrca-20240821_pre.xml (EX-101.PRE) — 11KB
- d890208d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Verrica Pharmaceuticals Inc. Date: August 27, 2024 /s/ P. Terence Kohler Jr. P. Terence Kohler Jr. Chief Financial Officer